UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

ERP57 Membrane Translocation Dictates the Immunogenicity of Tumor Cell Death by Controlling the Membrane Translocation of Calreticulin

The Journal of immunology (1950), 2008-08, Vol.181 (4), p.2533-2543

Obeid, Michel

2008

Volltextzugriff (PDF)

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

Nature reviews. Clinical oncology, 2019-09, Vol.16 (9), p.563-580

2019

Volltextzugriff (PDF)

New therapeutic perspectives to manage refractory immune checkpoint-related toxicities

The lancet oncology, 2019-01, Vol.20 (1), p.e54-e64

2019

Volltextzugriff (PDF)

Anticancer activity of targeted proapoptotic peptides and chemotherapy is highly improved by targeted cell surface calreticulin–inducer peptides

Molecular cancer therapeutics, 2009-09, Vol.8 (9), p.2693-2707

Obeid, Michel

2009

Volltextzugriff (PDF)

Calreticulin exposure dictates the immunogenicity of cancer cell death

Nature Medicine, 2007-01, Vol.13 (1), p.54-61

2007

Volltextzugriff (PDF)

Neoadjuvant Immunotherapy: A Promising New Standard of Care

International journal of molecular sciences, 2023-07, Vol.24 (14), p.11849

2023

Volltextzugriff (PDF)

Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial

Haematologica (Roma), 2023-01, Vol.108 (1), p.234-239

2023

Volltextzugriff (PDF)

Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma

Nature communications, 2024-04, Vol.15 (1), p.3664-3664, Article 3664

2024

Volltextzugriff (PDF)

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

The Journal of experimental medicine, 2005-12, Vol.202 (12), p.1691-1701

2005

Volltextzugriff (PDF)

Generating the Abscopal Effect by Combining Proapoptotic Peptides With IL-12-Based Immunotherapy

Neoplasia (New York, N.Y.), 2018-02, Vol.20 (2), p.193-196

2018

Volltextzugriff (PDF)

Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study

Journal for immunotherapy of cancer, 2021-11, Vol.9 (11), p.e003277

2021

Volltextzugriff (PDF)

A CD64/FcγRI-mediated mechanism hijacks PD-1 from PD-L1/2 interaction and enhances anti-PD-1 functional recovery of exhausted T cells

Frontiers in immunology, 2023-08, Vol.14, p.1213375-1213375

2023

Volltextzugriff (PDF)

A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy

Journal for immunotherapy of cancer, 2018-12, Vol.6 (1), p.156-7, Article 156

2018

Volltextzugriff (PDF)

A severe case of neuro-Sjögren's syndrome induced by pembrolizumab

Journal for immunotherapy of cancer, 2018-10, Vol.6 (1), p.110-110, Article 110

2018

Volltextzugriff (PDF)

A severe case of refractory esophageal stenosis induced by nivolumab and responding to personalized treatment

Journal of clinical oncology, 2019-03, Vol.37 (8_suppl), p.113-113

Obeid, Michel

2019

Volltextzugriff (PDF)

Ecto-calreticulin in immunogenic chemotherapy

Immunological reviews, 2007-12, Vol.220 (1), p.22-34

2007

Volltextzugriff (PDF)

Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events

Journal for immunotherapy of cancer, 2022-10, Vol.10 (10), p.e005635

2022

Volltextzugriff (PDF)

Leveraging the immune system during chemotherapy : Moving calreticulin to the cell surface converts apoptotic death from silent to immunogenic

Cancer research (Chicago, Ill.), 2007-09, Vol.67 (17), p.7941-7944

2007

Volltextzugriff (PDF)

Cytokine storm complicated by cardiogenic shock induced by anti-HER2 therapies

Journal for immunotherapy of cancer, 2023-06, Vol.11 (6), p.e006942

2023

Volltextzugriff (PDF)

A differential process mining analysis of COVID-19 management for cancer patients

Frontiers in oncology, 2022-12, Vol.12, p.1043675-1043675

2022

Volltextzugriff (PDF)

Reactivation of IgA vasculitis after COVID-19 vaccination

The Lancet. Rheumatology, 2021-09, Vol.3 (9), p.e617-e617

2021

Volltextzugriff (PDF)

Skin‐draining lymph node priming is sufficient to induce sterile immunity against pre‐erythrocytic malaria

EMBO molecular medicine, 2013-02, Vol.5 (2), p.250-263

2013

Volltextzugriff (PDF)

Allergologie-immunologie: Effets secondaires des immunothérapies du cancer : du travail pour l’immunologue clinique

Revue médicale suisse, 2019, Vol.15 (632-33), p.17-19

Obeid, Michel

2019

Volltextzugriff (PDF)

Personalized treatment of immune-related adverse events — balance is required

Nature reviews. Clinical oncology, 2020-08, Vol.17 (8), p.517-517

2020

Volltextzugriff (PDF)

Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts

Journal of clinical virology, 2005, Vol.32 (1), p.29-32

2005

Volltextzugriff (PDF)

1 – 25 von 144

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(139)
Mit Volltextzugriff
(118)

Publikationsform

Artikel
(143)
Bücher
(1)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

ERP57 Membrane Translocation Dictates the Immunogenicity of Tumor Cell Death by Controlling the Membrane Translocation of Calreticulin

Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance

New therapeutic perspectives to manage refractory immune checkpoint-related toxicities

Anticancer activity of targeted proapoptotic peptides and chemotherapy is highly improved by targeted cell surface calreticulin–inducer peptides

Calreticulin exposure dictates the immunogenicity of cancer cell death

Neoadjuvant Immunotherapy: A Promising New Standard of Care

Response-adjusted regimen combining ruxolitinib, etoposide and dexamethasone (adRED) in adult patients with acute myeloid leukemia-associated hemophagocytic lymphohistiocytosis: a single-center pilot trial

Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death

Generating the Abscopal Effect by Combining Proapoptotic Peptides With IL-12-Based Immunotherapy

Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study

A CD64/FcγRI-mediated mechanism hijacks PD-1 from PD-L1/2 interaction and enhances anti-PD-1 functional recovery of exhausted T cells

A severe case of refractory esophageal stenosis induced by nivolumab and responding to tocilizumab therapy

A severe case of neuro-Sjögren's syndrome induced by pembrolizumab

A severe case of refractory esophageal stenosis induced by nivolumab and responding to personalized treatment

Ecto-calreticulin in immunogenic chemotherapy

Systematic comparison with autoimmune liver disease identifies specific histological features of immune checkpoint inhibitor-related adverse events

Leveraging the immune system during chemotherapy : Moving calreticulin to the cell surface converts apoptotic death from silent to immunogenic

Cytokine storm complicated by cardiogenic shock induced by anti-HER2 therapies

A differential process mining analysis of COVID-19 management for cancer patients

Reactivation of IgA vasculitis after COVID-19 vaccination

Skin‐draining lymph node priming is sufficient to induce sterile immunity against pre‐erythrocytic malaria

Allergologie-immunologie: Effets secondaires des immunothérapies du cancer : du travail pour l’immunologue clinique

Personalized treatment of immune-related adverse events — balance is required

Detection of herpes simplex virus, cytomegalovirus and Epstein-Barr virus DNA in atherosclerotic plaques and in unaffected bypass grafts

Suchergebnisse filtern